Inc. ASRT,This commercial pharmaceutical company owns branded prescriptions and drug-delivery technologies in the fields of neurology, inflammation, and pain management.
May I ask what will happen to this stock with the reverse stock split please?
I’ve not seen anything posted on here about this stock and wondered what everyone’s thoughts were?
1 Like
Not sure why my reply didn’t carry into the merge but anyway……
With this hanging in the balance I would personally be very wary of getting involved. Purely my own opinion. DYOR and good luck.
Bausch, Assertio, Lupin must face antitrust claims over diabetes drug Glumetza | Reuters
Why is this Share so hot ?